MGF Protocol — Dosing & Research
Also known as: Mechano Growth Factor, IGF-1Ec, IGF-1 Splice Variant
Last Updated: April 4, 2026
⚠
Research-based dosing - under active validation
Based on current literature. Variability exists across study populations.
Under Review
Evidence Summary
Evidence Level
Preliminary
PubMed Studies
0+
Studied in:👤Human🐭Animal🧪Cell
Typical Dosage
100–200 mcg per injection (local)
Administration
Subcutaneous Injection
Administration Schedule
Variable
What is MGF?
Local intramuscular application. Activates PI3K-Akt and MAPK signaling for myotube fusion.
Research Applications
- Muscle hypertrophy research
- Mechanical load adaptation
- Satellite cell activation
- Injury-induced repair
- Skeletal muscle remodeling
Typical Protocol
Typical Protocol Duration
~1–2 hours
Half-Life
Mechanosensitive Splice Variant Of IGF-1 Produced By Muscle In Response To Mechanical Loading. Exhibits Local Paracrine Effects On Satellite Cells.
Safety
Safety context varies by dose, administration route, and protocol design. Review cited studies, protocol notes, and evidence level before interpreting outcomes.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.